Search results
New Hope for People With Aggressive Form of Lymphoma
US News & World Report· 5 hours agoAn experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma, researchers report. Rather, it simultaneously ...
As they enter their 60s, Gen Xers projected to see higher cancer rates than Boomers
WLRN Miami· 1 day agoAs they head into their golden years, Gen-Xers are more likely to be diagnosed with cancer than the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 21 hours agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
...Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory...
Morningstar· 6 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 4 days agoRelapsed/refractory (R/R...on T cells, providing T-cell-mediated cytotoxicity towards cancer cells....
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 3 days agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
Lung Cancer Drug Elicits Unprecedented Results in New Trial
GoodNewsNetwork· 2 days agoThe five-year results of a phase III trial present the longest progression-free survival data ever reported when treating non-small cell lung cancer (NSCLC ...
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike
Morningstar· 17 hours agoUSA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 4 days agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Digital Journal· 2 days agoTheralase...